Answers are grounded in this paper and cite their sources.
Most cancer therapies are seldom effective by using single anticancer drug therapeutics based on multiple tumor genetic alterations and molecular abnormalities. Drug combinations are commonly practiced in clinics. Yet, anticancer drug combination utilities need to transform from empirical to science-guided enterprises. This editorial offers the background knowledge of drug combination therapies by mathematical enquiry.
No takes yet. Share an insight, caveat, or question.
A 2016 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: